SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 273 filers reported holding SAGE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $6,510,000 | -85.2% | 226,679 | -62.8% | 0.07% | -77.5% |
| Q4 2019 | $43,945,000 | +7993.0% | 608,741 | +15613.5% | 0.32% | +8025.0% |
| Q3 2019 | $543,000 | -98.9% | 3,874 | -98.5% | 0.00% | -98.9% |
| Q2 2019 | $47,736,000 | +15.9% | 260,725 | +0.7% | 0.36% | +22.9% |
| Q1 2019 | $41,174,000 | +957.6% | 258,877 | +372.6% | 0.29% | +910.3% |
| Q1 2017 | $3,893,000 | -3.0% | 54,781 | -30.3% | 0.03% | -6.5% |
| Q4 2016 | $4,015,000 | -61.9% | 78,641 | -65.7% | 0.03% | -63.1% |
| Q3 2016 | $10,543,000 | – | 228,954 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,966,688 | $120,204,000 | 10.81% |
| Integral Health Asset Management, LLC | 230,000 | $14,058,000 | 4.30% |
| Asymmetry Capital Management, L.P. | 102,462 | $6,262,000 | 4.02% |
| ACUTA CAPITAL PARTNERS, LLC | 225,000 | $13,752,000 | 3.74% |
| DAFNA Capital Management LLC | 158,306 | $9,676,000 | 3.14% |
| Bain Capital Life Sciences Investors, LLC | 499,100 | $30,505,000 | 2.84% |
| Boxer Capital, LLC | 1,094,000 | $66,865,000 | 2.31% |
| Palo Alto Investors LP | 590,200 | $36,073,000 | 1.98% |
| Logos Global Management LP | 250,000 | $15,280,000 | 1.96% |
| Bellevue Group AG | 1,579,504 | $96,539,000 | 1.33% |